{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:40:34Z","timestamp":1793292034977,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015694","name":"Fondazione Cassa di Risparmio di Firenze","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003056","name":"Ente Cassa di Risparmio di Firenze","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["DFG INST208\/664"],"award-info":[{"award-number":["DFG INST208\/664"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.biopha.2024.117454","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T20:08:16Z","timestamp":1727208496000},"page":"117454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Histamine H3 receptor antagonist\/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection"],"prefix":"10.1016","volume":"180","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5143-9959","authenticated-orcid":false,"given":"Silvia","family":"Sgambellone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad A.","family":"Khanfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6745-8786","authenticated-orcid":false,"given":"Silvia","family":"Marri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0600-3682","authenticated-orcid":false,"given":"Serafina","family":"Villano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2374-5147","authenticated-orcid":false,"given":"Patrizia","family":"Nardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1514-2215","authenticated-orcid":false,"given":"David","family":"Reiner-Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3336-1710","authenticated-orcid":false,"given":"Holger","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lucarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.117454_bib1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"A.T. Broman, The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2024.117454_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bspc.2020.102137","article-title":"Classification of glaucoma using hybrid features with machine learning approaches","volume":"62","author":"Thakur","year":"2020","journal-title":"Biomed. Signal Process Control"},{"key":"10.1016\/j.biopha.2024.117454_bib3","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.biopha.2024.117454_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2015.06.001","article-title":"Autophagy in glaucoma: crosstalk with apoptosis and its implications","volume":"117","author":"Wang","year":"2015","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.biopha.2024.117454_bib5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ajo.2011.06.004","article-title":"An assessment of the health and economic burdens of glaucoma","volume":"152","author":"Varma","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2024.117454_bib6","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00417-018-4058-x","article-title":"Different glaucoma types and glaucoma surgeries among different age groups","volume":"256","author":"Tanito","year":"2018","journal-title":"Graefe\u2019S. Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.biopha.2024.117454_bib7","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.ajo.2012.12.007","article-title":"Association of open-angle glaucoma with perfusion pressure status in the Thessaloniki Eye Study","volume":"155","author":"Topouzis","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2024.117454_bib8","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fnins.2017.00478","article-title":"Investigations into hypoxia and oxidative stress at the optic nerve head in a rat model of glaucoma","volume":"11","author":"Chidlow","year":"2017","journal-title":"Front Neurosci."},{"key":"10.1016\/j.biopha.2024.117454_bib9","first-page":"224","article-title":"Oxygen and blood flow: players in the pathogenesis of glaucoma","volume":"14","author":"Mozaffarieh","year":"2008","journal-title":"Mol. Vis."},{"key":"10.1016\/j.biopha.2024.117454_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100916","article-title":"Inflammation in Glaucoma: from the back to the front of the eye, and beyond","volume":"83","author":"Baudouin","year":"2021","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.biopha.2024.117454_bib11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1350-9462(02)00008-3","article-title":"The impact of ocular blood flow in glaucoma","volume":"21","author":"Flammer","year":"2002","journal-title":"Prog. Retin Eye Res"},{"key":"10.1016\/j.biopha.2024.117454_bib12","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fncel.2017.00254","article-title":"Optic nerve degeneration after retinal ischemia\/reperfusion in a rodent model","volume":"11","author":"Renner","year":"2017","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.biopha.2024.117454_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1124\/jpet.110.170134","article-title":"Histamine H3 receptors and sleep-wake regulation","volume":"336","author":"Lin","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2024.117454_bib14","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1006\/exer.1996.0255","article-title":"I.H. Pang, Histamine induced contraction of human ciliary muscle cells","volume":"64","author":"Markwardt","year":"1997","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.biopha.2024.117454_bib15","unstructured":"S.D. Smith, D.S. Gregory, A circadian rhythm of aqueous flow underlies the circadian rhythm of IOP in NZW rabbits. | IOVS | ARVO Journals, Invest Ophthalmol Vis Sci (1989) 775\u2013778. https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2160758 (accessed April 12, 2021)."},{"key":"10.1016\/j.biopha.2024.117454_bib16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3390\/ijms20040981","article-title":"Role of histamine H3 receptor antagonists on intraocular pressure reduction in rabbit models of transient ocular hypertension and glaucoma","volume":"20","author":"Lanzi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.117454_bib17","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.neuroscience.2008.10.034","article-title":"Characterization of histamine projections and their potential cellular targets in the mouse retina","volume":"158","author":"Greferath","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2024.117454_bib18","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/cne.22731","article-title":"Histamine receptors of cones and horizontal cells in Old World monkey retinas","volume":"520","author":"Vila","year":"2012","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.biopha.2024.117454_bib19","doi-asserted-by":"crossref","first-page":"12939","DOI":"10.1002\/ange.201706072","article-title":"Multitarget-directed ligands combining cholinesterase and monoamine oxidase inhibition with histamine h3r antagonism for neurodegenerative diseases","volume":"129","author":"Bautista-Aguilera","year":"2017","journal-title":"Angew. Chem."},{"key":"10.1016\/j.biopha.2024.117454_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2016.00201","article-title":"Multiple targeting approaches on histamine H3 receptor antagonists","volume":"10","author":"Khanfar","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.biopha.2024.117454_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/vision5020029","article-title":"Nitric oxide interaction with the eye","volume":"5","author":"Erdinest","year":"2021","journal-title":"Vision"},{"key":"10.1016\/j.biopha.2024.117454_bib22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.brainres.2011.10.045","article-title":"Nitric oxide signaling in the retina: what have we learned in two decades?","volume":"1430","author":"Vielma","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2024.117454_bib23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exer.2017.05.013","article-title":"NO signaling in retinal bipolar cells","volume":"161","author":"Agurto","year":"2017","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.biopha.2024.117454_bib24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejphar.2019.01.041","article-title":"Ligand binding kinetics at histamine H3 receptors by fluorescence-polarization with real-time monitoring","volume":"848","author":"Reiner","year":"2019","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2024.117454_bib25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.22336\/rjo.2019.5","article-title":"The histaminergic control of the iridal vascular tone in rats and its influencing by topical administration of olopatadine and ranitidine","volume":"63","author":"Lunc\u0103","year":"2019","journal-title":"Rom. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2024.117454_bib26","first-page":"172","article-title":"Song, A study of experimental carbomer glaucoma and other experimental glaucoma in rabbits\u00a0- PubMed","volume":"38","author":"Xu","year":"2002","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"10.1016\/j.biopha.2024.117454_bib27","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/14756366.2011.597749","article-title":"A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology","volume":"27","author":"Fabrizi","year":"2012","journal-title":"J. Enzym. Inhib. Med Chem."},{"key":"10.1016\/j.biopha.2024.117454_bib28","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1089\/jop.2022.0004","article-title":"NCX 470 restores ocular hemodynamics and retinal cell physiology after ET-1-induced ischemia\/reperfusion injury of optic nerve and retina in rabbits","volume":"38","author":"Bastia","year":"2022","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2024.117454_bib29","doi-asserted-by":"crossref","DOI":"10.1007\/s10633-014-9473-7","article-title":"ISCEV Standard for full-field clinical electroretinography (2015 update)","volume":"130","author":"McCulloch","year":"2015","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.biopha.2024.117454_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bjp.0704879","article-title":"Protective effect of relaxin in cardiac anaphylaxis: involvement of the nitric oxide pathway","volume":"137","author":"Masini","year":"2002","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2024.117454_bib31","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/bjophthalmol-2011-300404","article-title":"The nitric oxide donating triamcinolone acetonide NCX 434 does not increase intraocular pressure and reduces endothelin-1 induced biochemical and functional changes in the rabbit eye","volume":"96","author":"Impagnatiello","year":"2012","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2024.117454_bib32","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/jcmm.12967","article-title":"HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-\u03b2\/SMAD signalling pathway","volume":"21","author":"Lucarini","year":"2017","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.biopha.2024.117454_bib33","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1111\/j.1582-4934.2012.01530.x","article-title":"The non-anticoagulant heparin-like K5 polysaccharide derivative K5-N,OSepi attenuates myocardial ischaemia\/reperfusion injury","volume":"16","author":"Collino","year":"2012","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.biopha.2024.117454_bib34","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.16202","article-title":"RUNX1 facilitates heart failure progression through regulating TGF-\u03b2-induced cardiac remodeling","volume":"11","author":"Qi","year":"2023","journal-title":"PeerJ"},{"key":"10.1016\/j.biopha.2024.117454_bib35","series-title":"Relationship between the Inhibition Constant (&) and the Concentration of Inhibitor Which Causes 50 Per Cent Inhibition (Iso) of an Enzymatic Reaction*","author":"Cheng","year":"1973"},{"key":"10.1016\/j.biopha.2024.117454_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2011.02.006","article-title":"A dual acting compound with latanoprost amide and nitric oxide releasing properties, shows ocular hypotensive effects in rabbits and dogs","volume":"93","author":"Impagnatiello","year":"2011","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.biopha.2024.117454_bib37","first-page":"564","article-title":"Elevated histamine levels in aqueous humor of patients with glaucoma","volume":"27","author":"Gowtham","year":"2021","journal-title":"Mol. Vis."},{"key":"10.1016\/j.biopha.2024.117454_bib38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000265476","article-title":"Histamine in the human eye","volume":"19","author":"Nowak","year":"1987","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.biopha.2024.117454_bib39","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1006\/exer.1996.0255","article-title":"I.H. Pang, Histamine induced contraction of human ciliary muscle cells","volume":"64","author":"Markwardt","year":"1997","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.biopha.2024.117454_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/S0039-6257(97)84043-X","article-title":"Nitric oxide in the eye: multifaceted roles and diverse outcomes","volume":"42","author":"Becquet","year":"1997","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.biopha.2024.117454_bib41","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1096\/fasebj.6.12.1381691","article-title":"Nitric oxide as a secretory product of mammalian cells","volume":"12","author":"Nathan","year":"1992","journal-title":"FASEB"},{"key":"10.1016\/j.biopha.2024.117454_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/antiox8110543","article-title":"Nitrosative stress in retinal pathologies: review","volume":"8","author":"Cant\u00f3","year":"2019","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2024.117454_bib43","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bmcl.2016.12.041","article-title":"New furoxan derivatives for the treatment of ocular hypertension","volume":"27","author":"Blangetti","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2024.117454_bib44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1600-0420.2000.tb01093.x","article-title":"Ocular haemodynamics and nitric oxide in normal pressure glaucoma","volume":"78","author":"Galassi","year":"2000","journal-title":"Acta Ophthalmol. Scand. Suppl."},{"key":"10.1016\/j.biopha.2024.117454_bib45","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/bjo.2003.028357","article-title":"E. Masini, Nitric oxide proxies and ocular perfusion pressure in primary open angle glaucoma","volume":"88","author":"Galassi","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2024.117454_bib46","unstructured":"D.\/ Mo, \/ Lim, D.\/ Ctl, \/ Boyd, Medical Officer\u2019s Review of NDA 207795 Class, (n.d.)."},{"key":"10.1016\/j.biopha.2024.117454_bib47","unstructured":"N.B.+ L. 2019. Vyzulta\u00ae [package insert]. Bridgewater, FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE VYZULTA \u00ae (latanoprostene bunod ophthalmic solution) 0, 2019. www.fda.gov\/medwatch."},{"key":"10.1016\/j.biopha.2024.117454_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2014.00038","article-title":"Regulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucoma","volume":"7","author":"Buys","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2024.117454_bib49","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1089\/jop.2016.0188","article-title":"The role of nitric oxide in the intraocular pressure lowering efficacy of latanoprostene bunod: review of nonclinical studies","volume":"34","author":"Cavet","year":"2018","journal-title":"J. Ocul. Pharm. Ther."},{"key":"10.1016\/j.biopha.2024.117454_bib50","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s12325-015-0260-y","article-title":"Evaluation of the effect of latanoprostene bunod ophthalmic solution, 0.024% in lowering intraocular pressure over 24h in healthy japanese subjects","volume":"32","author":"Araie","year":"2015","journal-title":"Adv. Ther."},{"key":"10.1016\/j.biopha.2024.117454_bib51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00347-021-01378-5","article-title":"Risk factors for open-angle glaucoma and recommendations for glaucoma screening","volume":"118","author":"Schuster","year":"2021","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.biopha.2024.117454_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2010.04.001","article-title":"Constitutive secretion of chemokines by cultured human trabecular meshwork cells","volume":"91","author":"Shifera","year":"2010","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.biopha.2024.117454_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.24826","article-title":"The dysfunction of the trabecular meshwork during glaucoma course","volume":"230","author":"Sacc\u00e0","year":"2015","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.biopha.2024.117454_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2005.09.182","article-title":"Induction of IL-6 expression by mechanical stress in the trabecular meshwork","volume":"337","author":"Liton","year":"2005","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.biopha.2024.117454_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/biom11101447","article-title":"The Histamine H4 receptor participates in the anti-neuropathic effect of the adenosine a3 receptor agonist IB-MECA: role of CD4+ T cells","volume":"11","author":"Micheli","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2024.117454_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms4334","article-title":"Histamine H3 receptors aggravate cerebral ischaemic injury by histamine-independent mechanisms","volume":"5","author":"Yan","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2024.117454_bib57","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/bjo.54.7.461","article-title":"Vasogenic origin of visual field defects and optic nerve changes in glaucoma","volume":"54","author":"Hayreh","year":"1970","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2024.117454_bib58","doi-asserted-by":"crossref","unstructured":"J. Flammer, Psychophysics in Glaucoma. A Modified Concept of the Disease, in: 1985: pp. 11\u201317. https:\/\/doi.org\/10.1007\/978-94-009-5516-5_2.","DOI":"10.1007\/978-94-009-5516-5_2"},{"key":"10.1016\/j.biopha.2024.117454_bib59","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1055\/s-2001-15883","article-title":"Glaucomatous optic neuropathy: a reperfusion injury","volume":"218","author":"Flammer","year":"2001","journal-title":"Klin. Monbl Augenheilkd."},{"key":"10.1016\/j.biopha.2024.117454_bib60","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3164734","article-title":"The role of the reactive oxygen species and oxidative stress in the pathomechanism of the age-related ocular diseases and other pathologies of the anterior and posterior eye segments in adults","volume":"2016","author":"Nita","year":"2016","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.biopha.2024.117454_bib61","article-title":"Normal-tension glaucoma: pathogenesis and genetics","volume":"17","author":"Trivli","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2024.117454_bib62","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.1985.248.5.C550","article-title":"Characterization of a coronary vasoconstrictor produced by cultured endothelial cells","volume":"248","author":"Hickey","year":"1985","journal-title":"Am. J. Physiol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224013404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224013404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:03:10Z","timestamp":1773968590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224013404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":62,"alternative-id":["S0753332224013404"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117454","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histamine H3 receptor antagonist\/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117454","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117454"}}